LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
TIDES: Oligonucleotides and Peptide Therapeutics
TIDES: Oligonucleotides and Peptide Therapeutics
Industry's largest & most renowned event series to accelerate your oligonucleotide and peptide therapeutics to market.

TIDES USA 2026

11 - 14. May 2026
North America’s leading meeting for advancing oligonucleotide, peptide, mRNA, genome editing and delivery innovations. Join top experts to explore discovery, development, CMC, manufacturing and commercialization strategies.
For more information click here
TIDES USA 2026

North America's premier forum for accelerating oligonucleotide, peptide, mRNA, genome editing and delivery innovations by sharing best-practices and novel strategies for discovery, development, CMC/manufacturing and commercialization.

TIDES USA 2026 TRACKS

  • Oligonucleotide Chemistry, Manufacturing & Controls
  • Oligonucleotide Discovery, Preclinical and Clinical
  • Peptide Chemistry, Manufacturing & Controls
  • Peptide Discovery, Preclinical and Clinical
  • mRNA Therapeutics/Vaccines & Genome Editing
  • Drug Delivery Innovations and Delivery of Macromolecules

Registration

Register now

Register by December 19 and Save Up to $1300/Participant

Registration fees

Industry Rate

  • Main Conference Pass + Recordings and Workshop Pass + Recordings [May 11-14]: $3,499.00
  • Main Conference Pass + Recordings [May 12-14]: $2,699.00

Academic or Government Rate

  • Main Conference Pass + Recordings and Workshop Pass + Recordings [May 11-14]: $1,249.00
  • Main Conference Pass + Recordings [May 20-22]: $949.00
Main Conference Pass + Recordings and Workshop Pass + Recordings [May 11-14] include:
  • Pre-conference workshops on May 11
  • All main conference sessions across all tracks from world-renowned speakers May 12-14.
  • Live-streaming for oligonucleotide conference tracks only
  • Pre-conference workshop on-demand sessions recordings for 1 year after the event pending speaker approval
  • Main conference on-demand sessions recordings for 1 year after the event pending speaker approval
  • Speaker presentation slides pending speaker approval
  • Exhibition Hall featuring 75+ live booths in the exhibit hall during May 12-14
  • Live poster presentations in poster hall
  • Networking opportunities: daily networking lunches and refreshment breaks during and digital networking opportunities throughout the event
  • Virtual exhibit and poster hall which consists of a majority of vendors and poster presenters from live event
  • The full attendee list, both live and digital only attendees, with capability to video chat, instant message and request meetings
Main Conference Pass + Recordings [May 12-14] include:
  • All main conference sessions across all tracks from world-renowned speakers May 12-14
  • Main conference on-demand sessions recordings for 1 year after the event pending speaker approval
  • Live-streaming for oligonucleotide conference tracks only
  • Speaker presentation slides pending speaker approval
  • Exhibition Hall featuring 75+ live booths in the exhibit hall during May 12-14
  • Live poster presentations in poster hall
  • Networking opportunities: daily networking lunches and refreshment breaks during and digital networking opportunities throughout the event
  • Virtual exhibit and poster hall which consists of a majority of vendors and poster presenters from live event
  • The full attendee list, both live and digital only attendees, with capability to video chat, instant message and request meetings

Program

Keynote Speakers

  • Robert S. Langer, ScD (David H. Koch Institute Professor, Massachusetts Institute of Technology)
  • Kiran Musunuru, MD, PhD (Barry J. Gertz Professor for Translational Research, Perelman School of Medicine, University of Pennsylvania)
  • Anastasia Khvorova, PhD (Professor, RNA Therapeutics Institute, UMass Chan Medical School)
  • Laura Sepp-Lorenzino, PhD (Biotech Executive, Board Member and Industry Advisor, GNMmeds LLC)
  • Michael Kopach, PhD (Associate Vice President, Synthetic Molecule Design and Development, Eli Lilly and Company)
  • James Powell (SVP, Manufacturing and Boulder Site Head, Novo Nordisk)
  • Ashok Bhandari, PhD (Executive Vice President, Chief Discovery Officer, Protagonist Therapeutics)
  • Vadim Dudkin, PhD (Founding Chief Technology Officer, Soufflé Therapeutics)

Sponsors

Diamond Sponsor

  • Nitto Avecia
  • Asymchem

Platinum Sponsors

  • Agilent Technologies

Gold Sponsors

  • Bachem
  • BioSpring
  • Chemgenes
  • Codexis
  • ST Pharm
  • Sumitomo

Venue

Hynes Convention Center

  • 900 Boylston St, Boston, MA 02115
  • Phone: +1 617 9542000
TIDES: Oligonucleotides and Peptide Therapeutics
LinkedIn Logo
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike